{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:00:42Z","timestamp":1783548042497,"version":"3.55.0"},"reference-count":48,"publisher":"American Psychiatric Association Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNP"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1176\/jnp.10.1.55","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T23:12:05Z","timestamp":1418857925000},"page":"55-63","source":"Crossref","is-referenced-by-count":47,"title":["Differential Neuropsychiatric Symptom Responses to Tacrine in Alzheimer's Disease"],"prefix":"10.1176","volume":"10","author":[{"given":"Daniel","family":"Kaufer","sequence":"first","affiliation":[{"name":"Received January 6, 1997; revised March 19, 1997; accepted March 27, 1997. From the Departments of Neurology and Psychiatry\/Biobehavioral Sciences, University of California at Los Angeles School of Medicine; the Behavioral Neuroscience Section, Psychiatry Service, and Nursing Service, West Los Angeles Veterans Affairs Medical Center, Los Angeles, California; and the Departments of Psychiatry and Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Address correspondence to Dr..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Cummings","sequence":"additional","affiliation":[{"name":"Received January 6, 1997; revised March 19, 1997; accepted March 27, 1997. From the Departments of Neurology and Psychiatry\/Biobehavioral Sciences, University of California at Los Angeles School of Medicine; the Behavioral Neuroscience Section, Psychiatry Service, and Nursing Service, West Los Angeles Veterans Affairs Medical Center, Los Angeles, California; and the Departments of Psychiatry and Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Address correspondence to Dr..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Christine","sequence":"additional","affiliation":[{"name":"Received January 6, 1997; revised March 19, 1997; accepted March 27, 1997. From the Departments of Neurology and Psychiatry\/Biobehavioral Sciences, University of California at Los Angeles School of Medicine; the Behavioral Neuroscience Section, Psychiatry Service, and Nursing Service, West Los Angeles Veterans Affairs Medical Center, Los Angeles, California; and the Departments of Psychiatry and Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Address correspondence to Dr..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R5P9040661","unstructured":"Cummings JL, Victoroff JI: Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1990; 3:140\u2013158"},{"key":"R5P9040662","doi-asserted-by":"crossref","unstructured":"Mega MS, Cummings JL, Fiorello T, et al: The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46:130\u2013135","DOI":"10.1212\/WNL.46.1.130"},{"key":"R5P9040663","doi-asserted-by":"crossref","unstructured":"Mangone CA, Sanguinetti RM, Baumann PD, et al: Influence of feelings of burden on the caregiver's perception of the patient's functional status. Dementia 1993; 4:287\u2013293","DOI":"10.1159\/000107335"},{"key":"R5P9040664","doi-asserted-by":"crossref","unstructured":"Perry EK, Tomlinson BE, Blessed G, et al: Correlation of cholinergic abnormalities with senile plaques and mental test scores in dementia. British Medical Journal 1978; 2:1457\u20131459","DOI":"10.1136\/bmj.2.6150.1457"},{"key":"R5P9040665","doi-asserted-by":"crossref","unstructured":"Bartus RT, Dean RL III, Beer B, et al: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217:408\u2013417","DOI":"10.1126\/science.7046051"},{"key":"R5P9040667","doi-asserted-by":"crossref","unstructured":"Eagger SA, Levy R, Sahakian BJ: Tacrine in Alzheimer's disease. Lancet 1991; 337:989\u2013992","DOI":"10.1016\/0140-6736(91)92656-M"},{"key":"R5P9040668","doi-asserted-by":"crossref","unstructured":"Knapp MJ, Knopman DS, Solomon PR, et al: A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271:985\u2013991","DOI":"10.1001\/jama.271.13.985"},{"key":"R5P9040669","doi-asserted-by":"crossref","unstructured":"Farlow M, Gracon S, Hershey L, et al: A controlled trial of tacrine in Alzheimer's disease: the Tacrine Study Group. JAMA 1992; 268:2523\u20132528","DOI":"10.1001\/jama.1992.03490180055026"},{"key":"R5P90406610","doi-asserted-by":"crossref","unstructured":"Sunderland T, Tariot PN, Cohen RM, et al: Anticholinergic sensitivity in patients with dementia of the Alzheimer's type and age-matched controls. Arch Gen Psychiatry 1987; 44:418\u2013426","DOI":"10.1001\/archpsyc.1987.01800170032006"},{"key":"R5P90406611","doi-asserted-by":"crossref","unstructured":"Cummings JL, Kaufer DI: Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996; 47:876\u2013883","DOI":"10.1212\/WNL.47.4.876"},{"key":"R5P90406612","doi-asserted-by":"crossref","unstructured":"Kaufer DI, Cummings, JL, Christine D: Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study. J Geriatr Psychiatry Neurol 1996; 9:1\u20136","DOI":"10.1177\/089198879600900101"},{"key":"R5P90406613","doi-asserted-by":"crossref","unstructured":"Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308\u20132314","DOI":"10.1212\/WNL.44.12.2308"},{"key":"R5P90406614","doi-asserted-by":"crossref","unstructured":"McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939\u2013944","DOI":"10.1212\/WNL.34.7.939"},{"key":"R5P90406615","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189\u2013198","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"R5P90406616","doi-asserted-by":"crossref","unstructured":"Wragg RE, Jeste DV: Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989; 146:577\u2013587","DOI":"10.1176\/ajp.146.5.577"},{"key":"R5P90406617","doi-asserted-by":"crossref","unstructured":"Flynn FG, Cummings JL, Gornbein J: Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates. J Neuropsychiatry Clin Neurosci 1991; 3:364\u2013370","DOI":"10.1176\/jnp.3.4.364"},{"key":"R5P90406618","doi-asserted-by":"crossref","unstructured":"Aarsland D, Cummings JL, Yenner G, et al: Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease. Am J Psychiatry 1996; 153:243\u2013247","DOI":"10.1176\/ajp.153.2.243"},{"key":"R5P90406619","doi-asserted-by":"crossref","unstructured":"Cummings JL, Ross W, Absher J, et al: Depressive symptoms in Alzheimer disease: assessment and determinants. Alzheimer Dis Assoc Disord 1995; 2:87\u201393","DOI":"10.1097\/00002093-199509020-00005"},{"key":"R5P90406620","doi-asserted-by":"crossref","unstructured":"Cummings JL, Gorman DG, Shapira J: Physostigmine ameliorates the delusions of Alzheimer's disease. Biol Psychiatry 1993; 33:536\u2013541","DOI":"10.1016\/0006-3223(93)90009-3"},{"key":"R5P90406621","unstructured":"Gorman DG, Read SR, Cummings JL: Cholinergic therapy of behavioral disturbances in Alzheimer's disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1993; 6:229\u2013234"},{"key":"R5P90406622","doi-asserted-by":"crossref","unstructured":"Perry EK, Marshall E, Kerwin JM, et al: Evidence of a monoaminergic:cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 1990; 55:1454\u20131456","DOI":"10.1111\/j.1471-4159.1990.tb03162.x"},{"key":"R5P90406623","unstructured":"Cummings JL: Psychosis in neurologic disease: neurobiology and pathogenesis. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1992; 5:144\u2013150"},{"key":"R5P90406624","doi-asserted-by":"crossref","unstructured":"Langlais PJ, Thal LJ, Hansen L, et al: Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 1993; 43:1927\u20131934","DOI":"10.1212\/WNL.43.10.1927"},{"key":"R5P90406625","doi-asserted-by":"crossref","unstructured":"Perry EK, Irving D, Kerwin JM, et al: Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 1993; 7:69\u201379","DOI":"10.1097\/00002093-199307020-00002"},{"key":"R5P90406626","doi-asserted-by":"crossref","unstructured":"McCormick DA: Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol 1992; 39:337\u2013388","DOI":"10.1016\/0301-0082(92)90012-4"},{"key":"R5P90406627","doi-asserted-by":"crossref","unstructured":"Perry EK, Perry RH: Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995; 28:240\u2013258","DOI":"10.1006\/brcg.1995.1255"},{"key":"R5P90406628","doi-asserted-by":"crossref","unstructured":"Liberini P, Valerio A, Memo M, et al: Lewy-body dementia and responsiveness to cholinesterase-inhibitors: a paradigm for heterogeneity in Alzheimer's disease? Trends Pharmacol Sci  1996; 17:155\u2013160","DOI":"10.1016\/0165-6147(96)81592-6"},{"key":"R5P90406629","doi-asserted-by":"crossref","unstructured":"McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report on the consortium on DLB international workshop. Neurology 1996; 47:1113\u20131124","DOI":"10.1212\/WNL.47.5.1113"},{"key":"R5P90406630","unstructured":"Cummings JL: Personality alterations in Alzheimer's disease: assessment and characterization. Bull Clin Neurosci 1989; 54:80\u201387"},{"key":"R5P90406632","doi-asserted-by":"crossref","unstructured":"Palmer AM, Stratmann GC, Procter AW, et al: Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann Neurol 1988; 23:616\u2013620","DOI":"10.1002\/ana.410230616"},{"key":"R5P90406633","doi-asserted-by":"crossref","unstructured":"Marin RS: Differential diagnosis and classification of apathy. Am J Psychiatry 1990; 147:22\u201330","DOI":"10.1176\/ajp.147.1.22"},{"key":"R5P90406634","doi-asserted-by":"crossref","unstructured":"Cummings JL: Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50:873\u2013880","DOI":"10.1001\/archneur.1993.00540080076020"},{"key":"R5P90406635","doi-asserted-by":"crossref","unstructured":"Adem A: Putative mechanisms of action of tacrine in Alzheimer's disease. Acta Neurol Scand Suppl 1992; 139:69\u201374","DOI":"10.1111\/j.1600-0404.1992.tb04458.x"},{"key":"R5P90406636","doi-asserted-by":"crossref","unstructured":"Zubenko GS, Moossey, Martinez J, et al: Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol 1991; 48:619\u2013624","DOI":"10.1001\/archneur.1991.00530180075020"},{"key":"R5P90406637","doi-asserted-by":"crossref","unstructured":"Palmer AM, DeKosky ST: Monoamine neurons in aging and Alzheimer's disease. J Neural Transm [Gen Sect] 1993; 91:135\u2013159","DOI":"10.1007\/BF01245229"},{"key":"R5P90406639","doi-asserted-by":"crossref","unstructured":"Soininen H, Unni L, Shillcutt S: Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain. Neurochem Res 1990; 15:1185\u20131190","DOI":"10.1007\/BF01208578"},{"key":"R5P90406640","doi-asserted-by":"crossref","unstructured":"Alhainen K, Helkala E-L, Reinikainen K, et al: The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease. J Neural Transm [P-D Sect] 1993; 5:185\u2013192","DOI":"10.1007\/BF02257673"},{"key":"R5P90406641","doi-asserted-by":"crossref","unstructured":"Freeman SE, Dawson RM: Tacrine: a pharmacological review. Prog Neurobiol 1991; 36:257\u2013277","DOI":"10.1016\/0301-0082(91)90002-I"},{"key":"R5P90406642","doi-asserted-by":"crossref","unstructured":"Soares JC, Gershon S: THA: historical aspects, review of pharmacological properties and therapeutic effects. Dementia 1995; 6:225\u2013234","DOI":"10.1159\/000106951"},{"key":"R5P90406643","doi-asserted-by":"crossref","unstructured":"Bierer LM, Haroutunian V, Gabriel, S, et al: Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of cholinergic deficits. J Neurochem 1995; 64:749\u2013760","DOI":"10.1046\/j.1471-4159.1995.64020749.x"},{"key":"R5P90406644","doi-asserted-by":"crossref","unstructured":"Arnold SE, Hyman BT, Flory J, et al: The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991; 1:103\u2013116","DOI":"10.1093\/cercor\/1.1.103"},{"key":"R5P90406645","unstructured":"Procter AW, Lowe, SL, Palmer AM, et al: Topographical distribution of neurochemical changes in Alzheimer's disease. Brain Res 1988; 14:939\u2013944"},{"key":"R5P90406646","doi-asserted-by":"crossref","unstructured":"Alhainen K, Helkala E-L, Riekkinen P: Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer's patients. Dementia 1993; 4:54\u201358","DOI":"10.1159\/000107296"},{"key":"R5P90406647","doi-asserted-by":"crossref","unstructured":"Sahakian BJ, Owen AM, Morant NJ, et al: Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 1993; 110:395\u2013401","DOI":"10.1007\/BF02244644"},{"key":"R5P90406648","doi-asserted-by":"crossref","unstructured":"Craig AH, Cummings JL, Fairbanks L, et al: Cerebral blood flow correlates of apathy in Alzheimer's disease. Arch Neurol 1996; 53:1116\u20131120","DOI":"10.1001\/archneur.1996.00550110056012"},{"key":"R5P90406649","doi-asserted-by":"crossref","unstructured":"Sultzer DL, Mahler ME, Mandelkern MA, et al: The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1995; 7:476\u2013484","DOI":"10.1176\/jnp.7.4.476"},{"key":"R5P90406650","doi-asserted-by":"crossref","unstructured":"Poirier J, Delisle MC, Quirion R, et al: Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc Nat Acad Sci USA 1995; 92:12260\u201312264","DOI":"10.1073\/pnas.92.26.12260"},{"key":"R5P90406651","doi-asserted-by":"crossref","unstructured":"Soininen H, Kosunen O, Helisalmi S, et al: A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer's patients carrying apolipoprotein epsilon 4 allele. Neurosci Lett 1995; 187:79\u201382","DOI":"10.1016\/0304-3940(95)11343-6"}],"container-title":["The Journal of Neuropsychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/jnp.10.1.55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T17:58:06Z","timestamp":1722448686000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/jnp.10.1.55"}},"subtitle":["Relationship to Dementia Severity"],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1176\/jnp.10.1.55"],"URL":"https:\/\/doi.org\/10.1176\/jnp.10.1.55","relation":{},"ISSN":["0895-0172","1545-7222"],"issn-type":[{"value":"0895-0172","type":"print"},{"value":"1545-7222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}